Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

NCT05636514

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Concord Repatriation and General Hospital Sydney, New South Wales, Australia
  • Nepean Hospital Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT04065399

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 57 locations
View Trial Details
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia
  • St. Anna Kinderkrebsforschung, CCRI Vienna, Austria
  • Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium
  • University Hospital Motol Prague, Czechia
View all 15 locations
View Trial Details
Recruiting

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT06918431

Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • City of Hope at Phoenix Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View Trial Details
Recruiting

Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

NCT06111638

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Southern Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Wuhan Union Hospital Affiliated to Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

NCT03838926

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • Vanda Investigational Site Washington D.C., District of Columbia, United States
  • Vanda Investigational Site Lafayette, Indiana, United States
  • Vanda Investigational Site Hackensack, New Jersey, United States
  • Vanda Investigational Site Seattle, Washington, United States
View Trial Details

Related conditions